共查询到20条相似文献,搜索用时 484 毫秒
1.
目的探讨全自动免疫组化筛查间变性淋巴瘤激酶(ALK)基因融合非小细胞肺癌的临床特点及病理特征.方法选取经病理检查确诊的554例非小细胞肺癌组织,采用Ventana抗ALK试剂和全自动免疫组化(IHC)染色检测ALK状态,分析ALK基因融合非小细胞肺癌的临床特点和病理特征.结果本次研究的554例非小细胞肺癌患者组织中,共筛选出34例ALK阳性,占6.14%;年龄60岁的非小细胞肺癌患者ALK阳性率8.69%,明显高于年龄≥60岁的3.62%,差异具有显著统计学意义(P0.01);男性患者ALK阳性率6.71%高于女性5.21%,但差异无统计学意义(P0.05).组织形态学方面,34例ALK阳性非小细胞肺癌中28例为肺腺癌,6例为非肺腺癌.16例实体型为主腺癌合并黏液产生,7例腺泡型为主腺癌,1例为乳头型为主腺癌,4例为浸润性黏液腺癌,4例为鳞状细胞癌.EGFR基因突变检测显示:仅有1例合并该基因突变,其余均为野生型.9例IHC阳性样本,9例ALK基因融合非小细胞肺癌,9例IHC阴性样本经荧光原位杂交技术检测和RT-PCR检测均为阴性结果,6例IHC染色可能为阳性,经荧光原位杂交技术检测均显示为ALK融合阴性.结论 ALK基因融合肺癌是非小细胞肺癌一新的分子亚型,具有独特的临床表现和病理形态;Ventana抗ALK试剂和IHC染色是检测ALK阳性非小细胞肺癌首选方法,对提高该类型肺癌的检出率及个体化治疗具有重要意义. 相似文献
2.
Chen Y Takita J Choi YL Kato M Ohira M Sanada M Wang L Soda M Kikuchi A Igarashi T Nakagawara A Hayashi Y Mano H Ogawa S 《Nature》2008,455(7215):971-974
Neuroblastoma in advanced stages is one of the most intractable paediatric cancers, even with recent therapeutic advances. Neuroblastoma harbours a variety of genetic changes, including a high frequency of MYCN amplification, loss of heterozygosity at 1p36 and 11q, and gain of genetic material from 17q, all of which have been implicated in the pathogenesis of neuroblastoma. However, the scarcity of reliable molecular targets has hampered the development of effective therapeutic agents targeting neuroblastoma. Here we show that the anaplastic lymphoma kinase (ALK), originally identified as a fusion kinase in a subtype of non-Hodgkin's lymphoma (NPM-ALK) and more recently in adenocarcinoma of lung (EML4-ALK), is also a frequent target of genetic alteration in advanced neuroblastoma. According to our genome-wide scans of genetic lesions in 215 primary neuroblastoma samples using high-density single-nucleotide polymorphism genotyping microarrays, the ALK locus, centromeric to the MYCN locus, was identified as a recurrent target of copy number gain and gene amplification. Furthermore, DNA sequencing of ALK revealed eight novel missense mutations in 13 out of 215 (6.1%) fresh tumours and 8 out of 24 (33%) neuroblastoma-derived cell lines. All but one mutation in the primary samples (12 out of 13) were found in stages 3-4 of the disease and were harboured in the kinase domain. The mutated kinases were autophosphorylated and displayed increased kinase activity compared with the wild-type kinase. They were able to transform NIH3T3 fibroblasts as shown by their colony formation ability in soft agar and their capacity to form tumours in nude mice. Furthermore, we demonstrate that downregulation of ALK through RNA interference suppresses proliferation of neuroblastoma cells harbouring mutated ALK. We anticipate that our findings will provide new insights into the pathogenesis of advanced neuroblastoma and that ALK-specific kinase inhibitors might improve its clinical outcome. 相似文献
3.
Stephens P Hunter C Bignell G Edkins S Davies H Teague J Stevens C O'Meara S Smith R Parker A Barthorpe A Blow M Brackenbury L Butler A Clarke O Cole J Dicks E Dike A Drozd A Edwards K Forbes S Foster R Gray K Greenman C Halliday K Hills K Kosmidou V Lugg R Menzies A Perry J Petty R Raine K Ratford L Shepherd R Small A Stephens Y Tofts C Varian J West S Widaa S Yates A Brasseur F Cooper CS Flanagan AM Knowles M Leung SY Louis DN Looijenga LH Malkowicz B Pierotti MA Teh B Chenevix-Trench G 《Nature》2004,431(7008):525-526
The protein-kinase family is the most frequently mutated gene family found in human cancer and faulty kinase enzymes are being investigated as promising targets for the design of antitumour therapies. We have sequenced the gene encoding the transmembrane protein tyrosine kinase ERBB2 (also known as HER2 or Neu) from 120 primary lung tumours and identified 4% that have mutations within the kinase domain; in the adenocarcinoma subtype of lung cancer, 10% of cases had mutations. ERBB2 inhibitors, which have so far proved to be ineffective in treating lung cancer, should now be clinically re-evaluated in the specific subset of patients with lung cancer whose tumours carry ERBB2 mutations. 相似文献
4.
miRNA在非小细胞肺癌的发生发展中发挥重要作用,为了解非小细胞肺癌患者外周血有核细胞的miRNA表达特征及其作用,采用第二代高通量测序技术对7例非小细胞肺癌患者和7例对照的外周血有核细胞miRNA表达水平进行检测,比较非小细胞肺癌患者与对照的外周血有核细胞miRNA表达特征,分析两者miRNA表达水平差异情况,共鉴定出非小细胞肺癌患者与对照的外周血有核细胞中有显著表达差异的miRNA 209种,其中肺癌样本miRNA表达上调的有138种,表达下调的有71种.研究结果显示非小细胞肺癌患者与对照样本的外周血有核细胞中miRNA表达具有显著差异,其中部分已被证实参与肿瘤发生、发展等过程. 相似文献
5.
转化生长因子β(TGF-β)信号转导通路的紊乱可使细胞逃避TGF-β介导的生长抑制效应,从而导致多种肿瘤的发生.本研究探讨了转化生长因子βⅠ型受体(TGFβRⅠ)在非小细胞肺癌(NSCLC)发生中的作用.采用免疫组化进行TGFβRⅠ基因的表达分析:采用单链构象多态性(SSCP)分析TGFβRⅠ基因结构的变异.结果发现37.2%NSCLC中TGFβRⅠ的表达下降,表明TGFβRⅠ在NSCLC发生中起着重要的作用.同时在TGFβRⅠ基因的第7号内含子中发现了一个单核苷酸多态性(SNP),该SNP与TGFβRⅠ的表达下降无显著关系(P>0.05). 相似文献
6.
Protein tyrosine kinases (PTKs) regulate cell proliferation, differentiation and are involved in signal
transduction. Uncontrolled signaling from receptor tyrosine kinases to intracellular tyrosine kinases can lead to inflamma
tory responses and diseases such as cancer and atherosclerosis. Thus, inhibitors that block the activity of tyrosine kinases
or the signaling pathways of PTKs activation could be assumed as the potential candidate for drug development. On this
assumption, we cloned and expressed the Abl PTK gene in E. coli, and purified the PTK, which was used to screen the
PTK inhibitors from the extracts of Chinese herbs. The catalytic domain sequence of PTK gene was amplified by PCR us
ing the cDNA of abl from Abelson murine leukemia virus as template. The amplified fragment was then cloned into the
GST-tagged expression vector pGEX2T. The recombinant plasmid was transformed into host cell E. coli DH5α and was
induced to express PTK protein. The expression of the protein was detected using SDS-PAGE. The result showed that a
specific protein was induced to express after 12 min induction, and reached peak level about 40% of the host total pro
tein after 4 h induction. The molecular weight of the fusion protein was about 58 kD. The purified GST-PTK fusion pro
tein presented higher activity for tyrosine phosphorylation. 相似文献
7.
Banerji S Cibulskis K Rangel-Escareno C Brown KK Carter SL Frederick AM Lawrence MS Sivachenko AY Sougnez C Zou L Cortes ML Fernandez-Lopez JC Peng S Ardlie KG Auclair D Bautista-Piña V Duke F Francis J Jung J Maffuz-Aziz A Onofrio RC Parkin M Pho NH Quintanar-Jurado V Ramos AH Rebollar-Vega R Rodriguez-Cuevas S Romero-Cordoba SL Schumacher SE Stransky N Thompson KM Uribe-Figueroa L Baselga J Beroukhim R Polyak K Sgroi DC Richardson AL Jimenez-Sanchez G Lander ES Gabriel SB Garraway LA Golub TR 《Nature》2012,486(7403):405-409
8.
目的:观察吉西他滨单药治疗老年晚期非小细胞肺癌(NSCLC)的疗效和毒性反应.方法:对28例NSCLC患者采用罔产吉西他滨1000mg/m^2,静脉注射30min,第1、8天,3~4周重复,2个周期后评价疗效.结果:28例均可评价疗效.总有效率(CR+PR)为30.6%(11/36),受益反应63.9%(23/36),毒副反应以骨髓抑制为常见.结论:吉西他滨单药治疗老年晚期NSCLC有较好疗效,毒性反应轻,患者易于耐受. 相似文献
9.
锯缘青蟹精氨酸激酶基因的克隆与表达 总被引:1,自引:0,他引:1
通过分子生物学方法,克隆得到锯缘青蟹(Scylla serrata)精氨酸激酶(Arginine Kinase,AK)开放阅读框基因序列.测序结果显示:该开放阅读框基因的序列长度为1 071 bp,编码356个氨基酸残基;该序列登录Genbank(GQ:851626),序列比对结果显示,锯缘青蟹精氨酸激酶与凡纳滨对虾(... 相似文献
10.
目的:研究转录因子Twist、上皮性钙黏附素(E-Cadherin)和波形蛋白(Vimention)在非小细胞肺癌(NSCLC)中的表达,探讨其与非小细胞肺癌浸润转移及预后之间的关系.方法:采用SP免疫组织化学、Western blot和RT-PCR方法检测80例非小细胞肺癌组织Twist、E-Cadherin和vimention蛋白和mRNA,20例癌旁正常组织作对照.另采用免疫细胞化学法检测68例非小细胞肺癌所致胸腔积液中肿瘤细胞的表达.结果:Twist和Vimentin在NSCLC组织及NSCLC胸水标本中的表达显著高于癌旁正常肺组织(P<0.01);E-cadherin在NSCLC组织及NSCLC胸水标本中表达显著低于癌旁正常肺组织(P<0.01);NSCLC组织中Twist及E-cadherin表达均与组织分化,临床分期及淋巴结转移情况密切相关(P<0.01);并且Twist表达与E-cadherin表达降低(P<0.01)和Vimentin的表达上调(P<0.01)之间都存在相关性.结论:Twist蛋白在非小细胞肺癌组织及胸腔转移灶中过度表达,可能通过分别上调和下调Vimentin、E-ead-h... 相似文献
11.
杜广营 《烟台大学学报(自然科学与工程版)》2008,21(1):40-45
研究目的:克隆表达人肠激酶轻链编码基因,以期应用于融合蛋白的切割与纯化.方法:从人的全基因组中扩增出编码人肠激酶轻链的5个外显子基因片段,经过酶切、连接后得到正确编码的人肠激酶轻链完整基因序列;随后,将目的基因片段插入原核表达载体pBV220中,构建成融合型表达载体pBV—EKL,转化大肠杆菌BL21(DE3),调节温度至42℃诱导重组蛋白表达;通过镍亲和层析纯化得到重组蛋白.结果:所表达的重组蛋白经SDS—PAGE分析,相对表观分子质量约为31kDa,表达量占菌体总可溶蛋白量的46%;通过镍亲和层析纯化得到的重组蛋白经复性后显示出具有催化切割活性.结论:成功构建了能大量表达重组人肠激酶轻链的菌株,为进一步进行重组人肠激酶活性的研究及其在生产和医学方面的应用研究奠定了基础. 相似文献
12.
S Seshagiri EW Stawiski S Durinck Z Modrusan EE Storm CB Conboy S Chaudhuri Y Guan V Janakiraman BS Jaiswal J Guillory C Ha GJ Dijkgraaf J Stinson F Gnad MA Huntley JD Degenhardt PM Haverty R Bourgon W Wang H Koeppen R Gentleman TK Starr Z Zhang DA Largaespada TD Wu FJ de Sauvage 《Nature》2012,488(7413):660-664
13.
为了获得重组猪生长激素抗体,对重组猪生长激素融合基因的真核表达产物进行免疫印迹(Western blot)检测,将利用DNA重组技术构建的重组质粒pPGH020在大肠杆菌(E.coli)BL21中进行诱导表达.表达产物经Ni+亲和层析柱纯化,获得纯化的重组猪生长激素融合蛋白.然后以此为抗原免疫新西兰大白兔,获得多克隆抗体,抗体再经硫铵沉淀、透析和亲和层析纯化.Western印迹结果表明,该纯化抗体显示了良好的免疫反应,其灵敏度比兔抗rpGH抗血清提高50倍,为猪生长激素融合基因在真核细胞的表达及功能鉴定奠定了基础. 相似文献
14.
采用荧光实时定量PCR的方法在48个非小细胞肺癌组织以及配对的正常肺组织中检测Eph/ephrin 基因的mRNA水平.发现肺癌组织中EphB4, EphB3 和 ephrin-A5的表达水平与配对的正常肺组织相比分别上调了60%,81%和65%,并具有显著的统计学差异. 而且,统计学分析发现ephrin-A5的表达水平与肿瘤分型、转移、性别、吸烟以及诊断年龄等临床病理学参数之间存在显著的相关性.此外,EphA2的表达水平与肿瘤大小、家族遗传史以及诊断年龄之间也存在显著的相关性.总之,这些结果提示EphB4, EphA2, EphB3 和ephrin-A5 在肺癌的发生和发展过程中可能以一种单独或者协同的形式发挥作用.这些蛋白有可能成为研究和诊断肺癌的重要靶向基因. 相似文献
15.
采用荧光实时定量PCR的方法在48个非小细胞肺癌组织以及配对的正常肺组织中检测Eph/ephrin 基因的mRNA水平.发现肺癌组织中EphB4, EphB3 和 ephrin-A5的表达水平与配对的正常肺组织相比分别上调了60%,81%和65%,并具有显著的统计学差异. 而且,统计学分析发现ephrin-A5的表达水平与肿瘤分型、转移、性别、吸烟以及诊断年龄等临床病理学参数之间存在显著的相关性.此外,EphA2的表达水平与肿瘤大小、家族遗传史以及诊断年龄之间也存在显著的相关性.总之,这些结果提示EphB4, EphA2, EphB3 和ephrin-A5 在肺癌的发生和发展过程中可能以一种单独或者协同的形式发挥作用.这些蛋白有可能成为研究和诊断肺癌的重要靶向基因. 相似文献
16.
目的:观察复方苦参注射液联合周剂量紫杉醇同步调强放射(intensity modulated radiation therapy,IMRT)治疗局部晚期非小细胞肺癌(non-small lung cancer,NSCLC)的放射性肺损伤及对生活质量的影响.方法:64例局部晚期非小细胞肺癌患者随机分为治疗组及对照组,32... 相似文献
17.
原核表达恶性疟原虫多期多表位基因并制备其多克隆抗体。在前期构建恶性疟原虫复合多期多表位重组真核表达载体的基础上,将测序正确的AMAMEG基因克隆入原核表达载体pGEX4T—1并诱导表达。采用包涵体洗涤的方式纯化目的蛋白,以AMA—1抗体对纯化蛋白进行Western—blot分析。将纯化的融合蛋白免疫小鼠制备多克隆抗体。通过PCR成功获得长度为1 000 bp的恶性疟原虫AMA—1胞外域基因片段,获得了与多表位基因连接后的AMAMEG基因。通过诱导表达,显示在相对分子量约95 000处有预计大小的特异性条带,表明成功表达出融合蛋白。经此纯化的融合蛋白免疫的小鼠能产生特异性抗体,其滴度达到1∶105。纯化的融合蛋白和多克隆抗体为研究新型疟疾疫苗奠定一定的理论和实践基础。 相似文献
18.
The long-term success of gene therapy for cancer relies heavily on the development of effective targeting systems. We investigate
the possibility of targeted gene therapy using promoter of carcinoembryonic antigen (CEA) gene. By using luciferase reporter
gene, we found that CEA promoter exhibit 16 times high activity in CEA-producing lung cancer cells, A549 than in nonproducing
cells, Hela. We also constructed a recombinant expression plasmid pCEATK, in which CEA promoter drives the effector gene,
thymidine kinase gene of Herpes Simplex Virus (HSVTK). A549 cells transfected with pCEATK became 865 times more sensitive
to ganciclovir (GCV) than the control cells. However, Hela cells transfected with this plasmid remained resistant to GCV.
These data indicate the potential for targeted gene therapy using the CEA promoter against CEA-producing tumor cells, such
as lung cancer cells.
Foundation item: Supported by the National Natural Science Foundation of China Natural Science Foundation of Hubei Province
Biography: XIAO Geng-fu(1966-), male, phD graduate candidate, Lecturer. 相似文献
19.
尝试应用基因工程技术制备一种兼具人超氧化物歧化酶(SOD)和过氧化氢酶(CAT)活性的双功能融合蛋白CAT-PTD-SOD,其中的PTD是序列为RKKRRQRRR的短肽.首先通过重叠PCR构筑CAT-PTD-SOD融合基因,然后把该基因转化进入大肠杆菌表达菌株Rosetta 2(DE3)菌株.通过SDS-PAGE、CAT和SOD活性分析以及分离纯化组分的分析确认该重组菌株能够表达CAT-PTD-SOD,其表达量可达总蛋白的8.9%,SDS-PAGE显示其分子量约为85 kD.可溶性实验发现该融合蛋白大部分以兼具SOD和CAT活性的可溶形式存在.抗H2O2能力实验表明CAT-PTD-SOD具有很好的抗H2O2能力,在0.033 mol.L-1、甚至0.067 mol.L-1的H2O2溶液中,其SOD活性20 min内无明显下降. 相似文献
20.
TR Wilson J Fridlyand Y Yan E Penuel L Burton E Chan J Peng E Lin Y Wang J Sosman A Ribas J Li J Moffat DP Sutherlin H Koeppen M Merchant R Neve J Settleman 《Nature》2012,487(7408):505-509
Mutationally activated kinases define a clinically validated class of targets for cancer drug therapy. However, the efficacy of kinase inhibitors in patients whose tumours harbour such alleles is invariably limited by innate or acquired drug resistance. The identification of resistance mechanisms has revealed a recurrent theme—the engagement of survival signals redundant to those transduced by the targeted kinase. Cancer cells typically express multiple receptor tyrosine kinases (RTKs) that mediate signals that converge on common critical downstream cell-survival effectors—most notably, phosphatidylinositol-3-OH kinase (PI(3)K) and mitogen-activated protein kinase (MAPK). Consequently, an increase in RTK-ligand levels, through autocrine tumour-cell production, paracrine contribution from tumour stroma or systemic production, could confer resistance to inhibitors of an oncogenic kinase with a similar signalling output. Here, using a panel of kinase-'addicted' human cancer cell lines, we found that most cells can be rescued from drug sensitivity by simply exposing them to one or more RTK ligands. Among the findings with clinical implications was the observation that hepatocyte growth factor (HGF) confers resistance to the BRAF inhibitor PLX4032 (vemurafenib) in BRAF-mutant melanoma cells. These observations highlight the extensive redundancy of RTK-transduced signalling in cancer cells and the potentially broad role of widely expressed RTK ligands in innate and acquired resistance to drugs targeting oncogenic kinases. 相似文献